Turnover, another important indicator of the market, rose 3.8 per cent to Tk 1,403 crore.
At the DSE, 218 stocks advanced, 71 fell and 73 remained unchanged.
Dhaka Insurance topped the gainers list that rose 9.92 per cent followed by Metro Spinning, Pioneer Insurance, Sonar Bangla Insurance and Rupali Bank.
Stocks of Beximco Ltd became the top traded stock with shares worth Tk 120 crore changing hands followed by Brac Bank, National Feed Mills, British American Tobacco, Robi Axiata, and Square Pharmaceuticals.
Shyampur Sugar Mills shed the most that lost 5 per cent followed by Pubali Bank, Appollo Ispat, Familytex Bangladesh, and Sunlife Insurance.
Stay updated on the go with The Daily Star Android & iOS News App. Click here to download it for your device.
Dhaka stocks hit three-month high
Stock investors are seen looking at a screen showing prices of different shares, at a brokerage house in Dhaka. Photo: Star/File
Star Business Report
Star Business Report
The benchmark index of the Dhaka bourse hits three-month high today thanks to the increased participation of high net-worth investors.
The DSEX, the main index of the Dhaka Stock Exchange (DSE), rose 39 points, or 0.70 per cent, to stand at 5,645.69.
The index ended the day at 5,646 on last February 4, according to data from the premier bourse.
Big investors are pouring funds in the market, which is helping the index to maintain a rising trend, said market analysts.
পুঁজিবাজারে বড় উত্থান ekushey-tv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ekushey-tv.com Daily Mail and Mail on Sunday newspapers.
Bangladeshi firm to make diabetes, malaria drugs in Kenya BUSINESS DAILY
One of Bangladesh’s largest drugmakers, Square Pharmaceuticals, will start producing medicines at its multibillion production facility in Kenya in the next four months, targeting unmet demand in Kenya, Tanzania, Rwanda, Burundi, Uganda and South Sudan.
The pharmaceutical firm started the construction of a plant in 2018 at the tax-friendly export processing zones (EPZ) in Athi River with an initial investment of Sh2.58 billion ($25 million) and now says it is ready to begin commercial production after the completion of the factory. Chemist developing medicine in laboratory
“We will hopefully be able to start manufacturing at the plant by July or August,” Tapan Chowdhury, managing director of Square Pharmaceuticals was quoted saying this week by local Bangladeshi media.
Bangladeshi firm to make diabetes, malaria drugs in Kenya
Friday May 07 2021
By BRIAN NGUGI
Summary
One of Bangladesh’s largest drugmakers, Square Pharmaceuticals, will start producing medicines at its multibillion production facility in Kenya in the next four months.
The pharmaceutical firm started the construction of a plant in 2018 at the tax-friendly export processing zones (EPZ) in Athi River with an initial investment of Sh2.58 billion ($25 million).
One of Bangladesh’s largest drugmakers, Square Pharmaceuticals, will start producing medicines at its multibillion production facility in Kenya in the next four months, targeting unmet demand in Kenya, Tanzania, Rwanda, Burundi, Uganda and South Sudan.